FTC Homeopathic Advertising Review Spurs Broader Disclaimer Suggestion, Opens New Stage For RCT Debate
This article was originally published in The Tan Sheet
Executive Summary
FTC attorneys say homeopathic claims should meet the same standard of proof the commission contends is required for dietary supplement advertising – randomized, controlled clinical trials. An industry groups says 92%-99% of participants in its study understood FDA does not review homeopathic drug label claims.
You may also be interested in...
OTC Homeopathy Group Revises Label Disclaimers In Light Of FTC Scrutiny
American Association of Homeopathic Pharmacists says its new recommended disclaimer for product labels – saying claims are not based on accepted medical evidence – is supported by research showing the language is clear to consumers.
OTC Homeopathy Group Revises Label Disclaimers In Light Of FTC Scrutiny
American Association of Homeopathic Pharmacists says its new recommended disclaimer for product labels – saying claims are not based on accepted medical evidence – is supported by research showing the language is clear to consumers.
OTC Homeopathic Labels Must Include Scientific Disclaimers – FTC
US trade regulator will require an "inherent contradiction" for homeopathic OTC labels: disclaimers to FDA-compliant label indications indicating a lack of scientific evidence that the product works.